Actinium Pharmaceuticals Inc. (Delaware) (ATNM) Financials

$1.22

$0.04 (3.39%)

As on 18-Sep-2026 16:19EDT

Market cap

$37 Mln

Revenue (TTM)

$35 Mln

P/E Ratio

3.5

P/B Ratio

1.3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	35.09	0.09	--	0.08	1.03	1.14
Cost of Revenue	-0.19	--	0.81	0.79	0.70	0.52
Gross Profit	35.49	0.09	-0.81	0.08	1.03	0.62
Operating Expenses	25.93	36.34	41.31	52.00	35.13	25.58
Operating Profit (EBIT)	9.56	-36.25	-42.12	-51.92	-34.10	-24.96
Other Income	--	--	--	--	--	--
Profit before Tax	11.31	-33.89	-38.24	-48.82	-33.02	-24.77
Provision for Tax	--	--	--	0.62	-1.09	-0.19
Profit after Tax (Net Income)	11.31	-33.89	-38.24	-48.82	-33.02	-24.77
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-33.02	-24.77

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	30.30	7.83	32.76	36.38	66.48	73.55
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.60	35.97	35.99	36.57	37.08	0.00
Current Liabilities	9.26	7.97	8.15	8.49	10.63	6.84
Total Liabilities	49.42	51.78	76.90	81.45	114.19	80.39

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	2.42	2.39	2.39	3.18	3.25	0.64
Current Assets	37.74	49.38	74.51	78.26	110.94	79.75
Total Assets	49.42	51.78	76.90	81.45	114.19	80.39
Total Debt*	1.34	1.69	1.57	2.11	2.58	0.31
Net Current Assets	28.48	41.41	66.36	69.77	100.31	72.91

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-24.58	-33.07	-47.34	8.64	-20.87
Cash Flow from Investing Activities	--	-0.10	-0.01	-0.15	-0.37	-0.13
Cash from Financing Activities	--	-0.22	29.32	14.87	23.11	35.22
Net Cash Inflow / Outflow	--	--	--	--	--	14.22

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	0.36	-1.09	-1.23	-1.77	-1.29	-1.15
Cash EPS ($)	0.34	-1.06	-1.20	-1.74	-1.26	-1.13
Adjusted Book Value ($)	0.96	0.25	1.05	1.32	2.59	3.41
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.79	-1.06	-1.71	0.34	-0.97
Free Cash Flow per Share ($)	--	-0.79	-1.06	-1.72	0.32	-0.97

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-154.53	-105.03	-90.78	-46.20	-36.46
ROE (%)	59.30	-166.96	-110.63	-94.92	-47.16	-36.74
ROA (%)	18.73	-52.67	-48.30	-49.91	-33.94	-33.76
EBIT Margin (%)	32.23	-37,652.22	--	-60,269.14	-3,205.53	-2,165.56
Net Margin (%)	32.23	-37,652.22	--	-60,269.14	-3,205.53	-2,165.56
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	4,232.10	--	-1.00	-0.92	-0.10	0.84
EBIT Growth (%)	127.56	11.39	21.66	-47.86	-33.27	-11.52
Net Profit Growth (%)	127.56	11.39	21.66	-47.86	-33.27	-11.52
EPS Growth (%)	127.09	0.11	0.31	-0.37	-0.12	0.05
Book Value Growth (%)	58.31	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	3.50	-1.25	-1.03	-2.88	-8.28	-5.23
Price / Book Value	1.29	5.42	1.20	3.86	4.11	1.76
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.37	0.12	0.86	-1.37	-5.17	-2.14
Close Price ($)	--	1.36	1.26	5.08	10.65	6.01
High Price ($)	--	2.41	10.24	14.70	15.12	10.30
Low Price ($)	--	1.03	1.10	4.00	4.41	5.70
Market Cap ($ Cr)	37.42	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.22	0.05	0.06	0.04	0.00
Short term debt to equity ratio	0.02	0.09	0.02	0.01	0.01	0.00
Current Ratio	4.08	6.20	9.14	9.21	10.44	11.66
Quick Ratio	4.08	--	--	--	--	--
Interest Coverage	--	--	--	--	-30.37	-130.39

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	0.58	0.00	--	0.00	0.01	0.02
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	3,495.10	4,180.26	4,092.73	3,441.64
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.